Abstract
This note summarises the main points that were made by the speakers and during the discussion. Report: The European Parliament Temporary Committee on Human Genetics and Other New Technologies in Human Medicine by Mr. T. Grunert, head of the secretariat of the temporary committee; Genetic Testing: State of the Art by Dr. K. Lindpaintner, head of Roche Genetics; Ethical Aspects of Population Screening by Prof. Dr. J.J. Cassiman, Center for Human Genetics, Leuven, Belgium; Public Attitudes and Debate on Genetic Testing by Dr. K. van der Bruggen, Rathenau Institute, the Netherlands; Genetic Tests and Insurance by Mr. R. Walsh, Association of British Insurers; Panel Discussion, Presentation by Ms. H. Tybkjaer, Danish Cystic Fibrosis Association; Presentation by Dr. J. Cream, Alzheimer's Society, United Kingdom; and Presentation by Ms. L. Cordier, European Commission DG Research. [KIE]
